A team of Tel Aviv University researchers claims to have made progress in the path to treating Parkinson’s disease. The team found that a variant of a protein, caused by a genetic mutation, enhances ...

Initiation of Phase 1b Study of GT-02287 in Parkinson's patients expected by end of 2024 BETHESDA, Md., Nov. 14, 2024 (GLOBE ...

The researchers: "We found that a variant of the TMEM16F protein, caused by a genetic mutation, enhances the spread of ...

Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

A fatal, highly hereditary illness with no disease-modifying treatments, Huntington’s is long overdue for a therapeutic win.

The past four years have brought disappointment for the Huntington’s community, but optimism is growing as companies ...

Researchers discovered alcohol use disorder (AUD) and Alzheimer's disease (AD) exhibit similar patterns of gene dysregulation, hinting that alcohol consumption may hasten Alzheimer’s progression.

Researchers have developed a method to analyze extracellular vesicles (EVs) in blood for early detection of Parkinson’s ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

Initially thought to simply react to neuron-derived pathology, genetic ... Parkinson’s disease. Microglia perform numerous homeostatic functions that support neuron health and counteract the ...

The neurological biomarkers market is expanding as neurological disorders, including dementia and Parkinson's disease, become more prevalent with an aging global population. Innovations in biomarker ...